Literature DB >> 3667621

Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study.

V Ellis1, M F Scully, V V Kakkar.   

Abstract

The kinetics of the activation of Glu- and Lys-plasminogen by single-chain urokinase (sc urokinase) derived from the transformed human kidney cell line TCL-598 have been studied and compared with two-chain urokinase (tc urokinase). Plasminogen activation was determined by the increase in fluorescence polarization of fluorescein-labeled aprotinin, a high affinity inhibitor of plasmin. This methodology allows plasmin generation by sc urokinase to be measured in functional isolation, with no interfering generation of tc urokinase, sc urokinase was found to activate plasminogen to plasmin with apparent Michaelis-Menten-type kinetics. The Km for Glu-plasminogen activation was 47.7 microM, with a catalytic constant of 2.91 min-1. Lys-plasminogen activation by sc urokinase was characterized by a Km of 11.7 microM and a kcat of 5.60 min-1. The Km values for the activation of Glu- and Lys-plasminogen by tc urokinase were found to be similar to those for activation by sc urokinase (36.8 and 9.0 microM, respectively), but the catalytic constants were higher at 36.0 and 118 min-1, respectively. Therefore, on the basis of the catalytic efficiency kcat/Km, sc urokinase seems to have 16-27-fold lower activity than tc urokinase. This activity of sc urokinase is in contrast to its lack of activity against a low molecular weight peptide substrate (less than 0.2% of the activity of sc urokinase). The activation of sc urokinase to tc urokinase by plasmin was also characterized (Km = 3.0 microM, kcat = 105 min-1). Using these data, it was possible to calculate the theoretical rate of plasminogen activation by sc urokinase in the absence of aprotinin, when tc urokinase is generated by the action of plasmin. The calculated rate was in good agreement with that determined experimentally using the chromogenic substrate D-Val-Leu-Lys-p-nitroanilide. These data demonstrate that sc urokinase has properties which distinguish it from conventional serine protease zymogens. The lack of activity against low molecular weight peptide substrates demonstrates the inaccessibility of the substrate-binding pocket. However, there is a moderate activity against plasminogen, suggesting that plasminogen may be acting as both an effector and a substrate for sc urokinase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3667621

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9.

Authors:  M G Martínez-Hernández; L A Baiza-Gutman; A Castillo-Trápala; D Randall Armant
Journal:  Reproduction       Date:  2010-11-12       Impact factor: 3.906

2.  Steady states and dynamics of urokinase-mediated plasmin activation in silico and in vitro.

Authors:  Lakshmi Venkatraman; Huipeng Li; C Forbes Dewey; Jacob K White; Sourav S Bhowmick; Hanry Yu; Lisa Tucker-Kellogg
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

3.  Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.

Authors:  J I Weitz; B Leslie
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

4.  Biochemical and structural analyses suggest that plasminogen activators coevolved with their cognate protein substrates and inhibitors.

Authors:  Agnieszka Jendroszek; Jeppe B Madsen; Andrés Chana-Muñoz; Daniel M Dupont; Anni Christensen; Frank Panitz; Ernst-Martin Füchtbauer; Simon C Lovell; Jan K Jensen
Journal:  J Biol Chem       Date:  2019-01-16       Impact factor: 5.157

5.  Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.

Authors:  J Pöllänen; A Vaheri; H Tapiovaara; E Riley; K Bertram; G Woodrow; R W Stephens
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

6.  Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans.

Authors:  J Grøndahl-Hansen; E Ralfkiaer; L T Kirkeby; P Kristensen; L R Lund; K Danø
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

7.  Plasmin triggers a switch-like decrease in thrombospondin-dependent activation of TGF-β1.

Authors:  Lakshmi Venkatraman; Ser-Mien Chia; Balakrishnan Chakrapani Narmada; Jacob K White; Sourav S Bhowmick; C Forbes Dewey; Peter T So; Lisa Tucker-Kellogg; Hanry Yu
Journal:  Biophys J       Date:  2012-09-05       Impact factor: 4.033

8.  Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).

Authors:  V Gurewich; R Pannell; R J Broeze; J Mao
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

9.  A key role for the urokinase plasminogen activator (uPA) in invasive Group A streptococcal infection.

Authors:  Martina L Sanderson-Smith; Yueling Zhang; Diane Ly; Deborah Donahue; Andrew Hollands; Victor Nizet; Marie Ranson; Victoria A Ploplis; Mark J Walker; Francis J Castellino
Journal:  PLoS Pathog       Date:  2013-07-04       Impact factor: 6.823

10.  Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.

Authors:  R W Stephens; J Pöllänen; H Tapiovaara; K C Leung; P S Sim; E M Salonen; E Rønne; N Behrendt; K Danø; A Vaheri
Journal:  J Cell Biol       Date:  1989-05       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.